Budget impact analysis resulting from the use of dabigatran etexilate in preventing stroke in patients with non-valvular atrial fibrillation in Italy. Farmeconomia. Health Economics and Therapeutic Pathways, [S. l.], v. 13, n. 3, p. 121–131, 2012. DOI: 10.7175/fe.v13i3.268. Disponível em: https://journals.seedstm.com/index.php/FE/article/view/268. Acesso em: 28 dec. 2025.